Orthoss Resorbable Bone Void Filler
Bone Grafting Material, Synthetic. 510(k) K014289, from Geistlich-Pharma (Washington, DC). Product code LYC, class 2.
As of Nov 19, 2026, K014289 is an FDA 510(k) held by Geistlich-Pharma, substantially equivalent on Mar 28, 2002 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
- Cited as a predicate by: 3 devices
ORTHOSIS is indicated for bony voids or gaps of the skeletal system (i.e. the extremities, spine and pelvis). ORTHOSS is indicated only for use in bone voids or gaps that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.
- Healos Ii Bone Graft SubstituteK081432 · Depuy Spine, Inc. · Aug 29, 2008
- Collagen Matrix Anorganic Bone Mineral Bone Graft MaterialsK062200 · Collagen Matrix, Inc. · Feb 13, 2007
- Ossimend (Tm) Bone Graft MaterialK052812 · Collagen Matrix, Inc. · Jan 25, 2006
- Cytrans™ ElashieldK253317 · GC America, Inc. · Jul 6, 2026
- Bonalive MaxillofacialK253883 · Bonalive , Ltd. · May 14, 2026
- Bontree PlusK251818 · Hudens Bio Co., Ltd. · Mar 6, 2026
- FG Bone Graft MK244006 · Full Golden Biotech Co., Ltd. · Sep 17, 2025
- FG Bone Graft BK243745 · Full Golden Biotech Corporation · Aug 29, 2025
- Synthetic Bone Graft ParticulateK241186 · Shenzhen Dazhou Medical Technology Co., Ltd. · Feb 21, 2025
- CMFlexTMK213260 · Dimension Inx Corp. · Dec 30, 2022
- InRoad® Dental Synthetic Bone GraftK202675 · Osteogene Tech Corp · Mar 4, 2022
- Type
- Traditional
- Received
- Dec 28, 2001
- Review panel
- Dental
- Regulation
- 21 CFR 872.3930
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files